Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
La Revue Du Praticien
|
April 1, 2003
[In clinical practice]
Bertrand Delaisi, Michèle Gérardin
The Journal of Allergy and Clinical Immunology. in Practice
|
April 14, 2021
Asthma may not be a risk factor for severe COVID-19 in children
Flore Amat, Bertrand Delaisi, Jean-Philippe Labbé, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 13, 2011
Recurrent abdominal pain in children with cystic fibrosis: a pilot prospective longitudinal evaluation of characteristics and management
Anne Munck, Anne Pesle, Cécile Cunin-Roy, et al.
Pulmonary Pharmacology & Therapeutics
|
March 19, 2017
Vibrating-mesh nebulizer maintenance by CF patients: Results from a French survey
Melisande Baravalle-Einaudi, Nadine Dufeu, Christian Dupont, et al.
The Lancet Regional Health. Europe
|
November 5, 2024
Correction to "Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)" [The Lancet Regional Health - Europe 41 (2024) 100915]
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, et al.
The Lancet Regional Health. Europe
|
May 6, 2024
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, et al.
Journal of Investigational Allergology & Clinical Immunology
|
December 11, 2025
Impact of Liquid Sublingual Immunotherapy on Health Care Resource Use in Allergic Rhinitis and Asthma in the Real-world EfficAPSI Study
Philippe Devillier, Pascal Demoly, Jean-François Bergmann, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
August 5, 2009
Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis
Dominique Hubert, Sylvie Leroy, Raphaële Nove-Josserand, et al.
Expert Review of Clinical Immunology
|
December 19, 2023
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort
Philippe Devillier, Mathieu Molimard, Jean-François Bergmann, et al.
Clinical and Translational Allergy
|
February 20, 2013
Assessment of disease control in allergic rhinitis
Pascal Demoly, Moises A Calderon, Thomas Casale, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
La Revue Du Praticien
|
April 1, 2003
[In clinical practice]
Bertrand Delaisi, Michèle Gérardin
The Journal of Allergy and Clinical Immunology. in Practice
|
April 14, 2021
Asthma may not be a risk factor for severe COVID-19 in children
Flore Amat, Bertrand Delaisi, Jean-Philippe Labbé, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 13, 2011
Recurrent abdominal pain in children with cystic fibrosis: a pilot prospective longitudinal evaluation of characteristics and management
Anne Munck, Anne Pesle, Cécile Cunin-Roy, et al.
Pulmonary Pharmacology & Therapeutics
|
March 19, 2017
Vibrating-mesh nebulizer maintenance by CF patients: Results from a French survey
Melisande Baravalle-Einaudi, Nadine Dufeu, Christian Dupont, et al.
The Lancet Regional Health. Europe
|
November 5, 2024
Correction to "Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)" [The Lancet Regional Health - Europe 41 (2024) 100915]
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, et al.
The Lancet Regional Health. Europe
|
May 6, 2024
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, et al.
Journal of Investigational Allergology & Clinical Immunology
|
December 11, 2025
Impact of Liquid Sublingual Immunotherapy on Health Care Resource Use in Allergic Rhinitis and Asthma in the Real-world EfficAPSI Study
Philippe Devillier, Pascal Demoly, Jean-François Bergmann, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
August 5, 2009
Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis
Dominique Hubert, Sylvie Leroy, Raphaële Nove-Josserand, et al.
Expert Review of Clinical Immunology
|
December 19, 2023
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort
Philippe Devillier, Mathieu Molimard, Jean-François Bergmann, et al.
Clinical and Translational Allergy
|
February 20, 2013
Assessment of disease control in allergic rhinitis
Pascal Demoly, Moises A Calderon, Thomas Casale, et al.
Page
of 2